ustekinumab 45 MG in 0.5 mL Injection
- RxCUI
- 1654077
- RxNorm name
- ustekinumab 45 MG in 0.5 mL Injection
- Display name
- ustekinumab 45 MG in 0.5 mL Injection
- Full name
- ustekinumab 45 MG in 0.5 mL Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ustekinumab | USTEKINUMAB | Janssen Biotech, Inc. | 23b486eb-f48d-47d4-815e-1313d4ebfbfa | 2026-07-23 | Warnings, Adverse reactions | 1654077 |
| Stelara | USTEKINUMAB | Janssen Biotech, Inc. | c77a9664-e3bb-4023-b400-127aa53bca2b | 2026-07-21 | Warnings, Adverse reactions | 1654077 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c77a9664-e3bb-4023-b400-127aa53bca2b | ustekinumab 45 MG in 0.5 mL Injection | PSN | 47 | These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA ® (ustekinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009 | 20260422 |
| c77a9664-e3bb-4023-b400-127aa53bca2b | 0.5 ML ustekinumab 90 MG/ML Injection | SCD | 47 | These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA ® (ustekinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009 | 20260422 |
| c77a9664-e3bb-4023-b400-127aa53bca2b | ustekinumab 45 MG per 0.5 ML Injection | SY | 47 | These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA ® (ustekinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009 | 20260422 |
| 23b486eb-f48d-47d4-815e-1313d4ebfbfa | ustekinumab 45 MG per 0.5 ML Injection | SY | 6 | These highlights do not include all the information needed to use Ustekinumab safely and effectively. See full prescribing information for USTEKINUMAB. Ustekinumab injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009 | 20260424 |
| 23b486eb-f48d-47d4-815e-1313d4ebfbfa | ustekinumab 45 MG in 0.5 mL Injection | PSN | 6 | These highlights do not include all the information needed to use Ustekinumab safely and effectively. See full prescribing information for USTEKINUMAB. Ustekinumab injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009 | 20260424 |
| 23b486eb-f48d-47d4-815e-1313d4ebfbfa | 0.5 ML ustekinumab 90 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use Ustekinumab safely and effectively. See full prescribing information for USTEKINUMAB. Ustekinumab injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009 | 20260424 |